TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 1 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,887,000 | -14.0% | 25,078 | -69.3% | 0.00% | 0.0% |
Q1 2022 | $2,193,000 | -43.7% | 81,681 | +0.1% | 0.00% | -50.0% |
Q4 2021 | $3,892,000 | -34.1% | 81,588 | -8.2% | 0.00% | -33.3% |
Q3 2021 | $5,903,000 | -6.5% | 88,866 | +9.9% | 0.00% | 0.0% |
Q2 2021 | $6,310,000 | +19.2% | 80,869 | +44.5% | 0.00% | 0.0% |
Q1 2021 | $5,294,000 | -26.4% | 55,972 | -5.2% | 0.00% | -25.0% |
Q4 2020 | $7,195,000 | +210.3% | 59,042 | +122.4% | 0.00% | +100.0% |
Q3 2020 | $2,319,000 | +20.2% | 26,549 | -11.2% | 0.00% | +100.0% |
Q2 2020 | $1,930,000 | +126.3% | 29,892 | +56.6% | 0.00% | 0.0% |
Q1 2020 | $853,000 | -5.3% | 19,093 | +31.6% | 0.00% | 0.0% |
Q4 2019 | $901,000 | +1101.3% | 14,505 | +602.4% | 0.00% | – |
Q3 2019 | $75,000 | -77.9% | 2,065 | -75.4% | 0.00% | – |
Q2 2019 | $339,000 | – | 8,385 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 2,737,297 | $176,802,000 | 6.75% |
MPM BioImpact LLC | 308,686 | $19,938,000 | 5.30% |
Burrage Capital Management LLC | 77,172 | $4,985,000 | 3.49% |
Orbimed Advisors | 2,745,327 | $177,321,000 | 2.50% |
Parkman Healthcare Partners LLC | 110,318 | $7,125,000 | 2.01% |
SECTORAL ASSET MANAGEMENT INC | 284,486 | $18,375,000 | 1.69% |
First Light Asset Management, LLC | 192,829 | $12,455,000 | 1.45% |
Asymmetry Capital Management, L.P. | 22,608 | $1,460,000 | 1.12% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,236,000 | 0.74% |
Prosight Management, LP | 25,602 | $1,654,000 | 0.71% |